FDA encourages manufacturers to develop abuse-deterrent drugs
2 April 2015 | By Victoria White
The U.S. FDA has issued final guidance to assist industry in developing opioid drug products with potentially abuse-deterrent properties...
List view / Grid view
2 April 2015 | By Victoria White
The U.S. FDA has issued final guidance to assist industry in developing opioid drug products with potentially abuse-deterrent properties...
1 April 2015 | By Victoria White
A consortium will collaborate with Basilea to progress a new family of cancer drugs designed to block several key cancer-causing proteins at once...
31 March 2015 | By Victoria White
Selvita announced today that it is commencing IND-enabling studies for SEL24 project, the company’s first oncology drug candidate...
31 March 2015 | By Victoria White
Invectys has announced fundraising of 1.7 million euros from its original group of private investors, accelerating the clinical development of INVAC-1...
31 March 2015 | By Victoria White
AstraZeneca has joined with Genomics England to accelerate the development of new diagnostics and treatments arising from the 100,000 Genomes Project...
31 March 2015 | By Victoria White
Norvatis and Aduro have entered an alliance that is focused on the discovery of cancer immunotherapies and launched a new immuno-oncology research group...
31 March 2015 | By Victoria White
Pfizer Inc. has announced that Charles Reay Mackay will join the company as Chief Scientific Officer for Pfizer’s Inflammation and Immunology Research Unit...
31 March 2015 | By Victoria White
Merck Serono and Intrexon Corporation have announced an exclusive collaboration and license agreement to develop and commercialise CAR-T cancer therapies...
30 March 2015 | By Victoria White
CRT and BioInvent have announced the start of a two-year research collaboration with leading antibody researchers at the University of Southampton...
30 March 2015 | By Victoria White
Around 6.5 million Europeans currently suffer from AMD. Nanoparticles could potentially be used as carriers for drug treatments instead of injections...
30 March 2015 | By Victoria White
The MRC and UCB are to launch a collaboration that will provide scientists with access to cutting-edge technologies to discover new monoclonal antibodies...
30 March 2015 | By Victoria White
A new trial of the drug Abatacept could bring hope to the millions of Britons who are likely to one day suffer from rheumatoid arthritis...
30 March 2015 | By Victoria White
Cellectis has announced the pricing of its initial public offering of 5,500,000 ADSs at a price to the public of $41.50 per ADS...
27 March 2015 | By Victoria White
PHE scientists are heading a consortium researching a rapid ‘in the field’ Ebola test, following the successful award of IMI funding...
26 March 2015 | By Victoria White
Scientists have revealed a brand new function for one of the first cancer genes ever discovered – the retinoblastoma gene...